Clinical Trials Directory

Trials / Completed

CompletedNCT02479529

Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

After cardiac surgery, vasoplegic syndrome is a hemodynamic state characterized by profound hypotension associated with a decrease in systemic vascular resistance. The care of this disease is based on the intravenous administration of a vasopressor, usually norepinephrine. During the recovery phase, weaning of norepinephrine, is an important step in which any lack of preload (blood volume) initial or secondary can be, and increase tissue malperfusion.

Conditions

Interventions

TypeNameDescription
DRUGNorepinephrineAdministration and weaning of norepinephrine is based on dynamic arterial elastance
DRUGNorepinephrineThe usual procedure of withdrawal norepinephrine is based on hemodynamic parameters (blood pressure, cardiac output), clinical (cutaneous perfusion, mottling, hourly diuresis) and biological (SVO2, arterial lactate).

Timeline

Start date
2014-10-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-06-24
Last updated
2025-09-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02479529. Inclusion in this directory is not an endorsement.